Form 4: Celestica Director Wilson Reports Share Transactions
Insider Transaction Report
Celestica Inc. Director Michael Max Wilson reported the acquisition of common shares and deferred share units, alongside the vesting and disposition of restricted share units.
Summary
- Director Michael Max Wilson of Celestica Inc. reported transactions on March 31, 2025, involving common shares, Restricted Share Units (RSUs), and Deferred Share Units (DSUs).
- Acquired 5,717 common shares directly, which resulted from the vesting and disposition of RSUs.
- Acquired 1,300 Deferred Share Units (DSUs) directly, increasing total direct DSU beneficial ownership to 284,431.
- Disposed of 2,517 RSUs from a March 31, 2022 grant, resulting in 0 RSUs remaining from that specific grant.
- Disposed of 2,440 RSUs from a March 31, 2023 grant, with 2,439 RSUs remaining from that specific grant.
- Disposed of 760 RSUs from a March 31, 2024 grant, with 1,520 RSUs remaining from that specific grant.
- Each RSU represents a contingent right to receive one common share or an equivalent value in cash, vesting 1/3 annually over 3 years.
- Each DSU represents a contingent right to receive one common share or an equivalent value in cash at the Issuer's discretion when the holder ceases to be a director or employee.
Sentiment
Score: 6
Explanation: The director acquired common shares through RSU vesting and increased Deferred Share Unit holdings, which generally signals continued alignment with shareholder interests.
Positives
- Director Michael Max Wilson acquired 5,717 common shares directly through the vesting of Restricted Share Units, increasing his direct common share holdings to 7,501.
- Director Michael Max Wilson acquired an additional 1,300 Deferred Share Units (DSUs), increasing his total direct DSU beneficial ownership to 284,431. The acquisition of DSUs aligns director interests with long-term shareholder value as they are typically paid out upon cessation of service.
Negatives
- The disposition of 5,717 Restricted Share Units (RSUs) across three different grants (2022, 2023, 2024) represents a reduction in the director's derivative holdings, although these were converted into common shares.
Future Outlook
The filing details the vesting schedule for Restricted Share Units, with 1/3 vesting annually over three years from their respective grant dates. Deferred Share Units are contingent rights to receive common shares or cash when the holder ceases to be a director or employee.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions and does not provide broader industry context or trends. It reflects a director's personal holdings and compensation-related share movements within Celestica Inc.
Stakeholder Impact
- Shareholders: The transactions indicate a director's continued alignment with shareholder interests through the acquisition of common shares and an increase in Deferred Share Units, which are typically long-term incentive vehicles.
Key Dates
| Date | Description |
|---|---|
| 03/31/2022 | Grant date for 7,550 Restricted Share Units (RSUs) to the reporting person. |
| 03/31/2023 | Grant date for 7,318 Restricted Share Units (RSUs) to the reporting person. |
| 03/31/2024 | Grant date for 2,280 Restricted Share Units (RSUs) to the reporting person. |
| 03/31/2025 | Date of earliest transaction reported, involving the acquisition of common shares and DSUs, and disposition of RSUs. |
| 04/02/2025 | Signature date of the reporting person's attorney-in-fact for the filing. |
Keywords
Celestica, CLS, Form 4, Insider Transaction, Beneficial Ownership, Restricted Share Units, Deferred Share Units, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.